Streetbeat News

Products Services

NHC

National HealthCare Corporation (NHC) announced its plan to acquire White Oak Senior Living Portfolio in North and South Carolina, which includes a long-term care pharmacy. The transaction is expected to close in Q3 2024.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 6:34 pm

PBYI

Puma Biotechnology presented a Phase I/Ib study on Alisertib for treating Osimertinib-resistant EGFR-mutated lung cancer at ASCO 2024.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 6:33 pm

JNJ

Johnson & Johnson announced new Phase 2 data from the PALOMA-2 study showing that subcutaneous amivantamab combined with lazertinib provides a clinically meaningful antitumor response and improved safety profile in patients with EGFR-mutated non-small cell lung cancer. The results were presented at the 2024 ASCO Annual Meeting.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 6:33 pm

MRUS

Merus N.V. (NASDAQ:MRUS) presented a poster at the 2024 ASCO Annual Meeting showcasing the single-agent efficiency of MCLA-129 in METex14 NSCLC.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 6:31 pm

ARW

AVGO

Arrow Electronics has signed a new distribution agreement with VMWare and Broadcom in Europe, which could enhance its product offerings and market reach.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 6:21 pm

OCX

Oncocyte's VitaGraft Kidney Diagnostic Test has shown promising Phase 2 results in transplant monitoring, as published in the New England Journal of Medicine.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 6:15 pm

AFMD

Affimed N.V. (NASDAQ: AFMD) shares surged on Monday following the release of promising clinical data from its AFM24-102 study in non-small cell lung cancer (NSCLC). The data showed significant clinical efficacy and a manageable safety profile for the combination of AFM24 and atezolizumab, leading to an 81.4% increase in AFMD's stock price.

Portfolio Pulse from Vandana Singh

June 03, 2024 | 6:13 pm

BP

COP

CVX

OXY

XOM

Shares of several oil & gas companies are trading lower following an OPEC+ meeting in which members announced they would start phasing out voluntary production cuts in October.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 6:08 pm

LLY

Eli Lilly has entered into an exclusive license agreement with QurAlis Corporation to develop and commercialize QRL-204, a preclinical compound targeting ALS and dementia. The deal includes an upfront payment of $45 million, potential milestone payments up to $577 million, and tiered royalties on net sales. The agreement also involves a research collaboration to develop additional candidates targeting UNC13A.

Portfolio Pulse from Vandana Singh

June 03, 2024 | 6:05 pm

AAPL

BABA

CGRO

CLIX

Alibaba's 618 Shopping Festival shows strong sales momentum with major brands like Apple and Xiaomi leading the way. Alibaba aims for double-digit revenue growth by 2027, supported by a stable regulatory environment and consumer spending. The company is also expanding its global cloud reach.

Portfolio Pulse from Anusuya Lahiri

June 03, 2024 | 5:59 pm